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Methicillin-resistant  Staphylococcus aureus (MRSA) 
clonal type ST398 is usually associated with animals. We 
examined 1,098 conﬁ   rmed MRSA samples from human 
patients and found that 21 were MRSA ST398. Most (16) 
patients were farmers. Increasing prevalence from 1.3% 
(2006) to 2.5% (2008) shows emergence of MRSA ST398 
in humans in Austria.  
I
n the past few years, interest has focused on the emer-
gence of methicillin-resistant Staphylococcus aureus 
(MRSA) in animals and the potential for cross-transmission 
between humans and animals (1). MRSA isolates that are 
strongly associated with pigs or contact with pigs show at 
least 2 similarities: they are not typeable by pulsed-ﬁ  eld gel 
electrophoresis (PFGE) because their DNA cannot be di-
gested by the restriction enzyme SmaI (2), and most belong 
to the MRSA clonal lineage sequence type (ST) 398 (1).
The Study
From January 2006 through May 2008, a total of 21 
laboratories and/or hospitals in Upper Austria (project 
MRSA-Registry Upper Austria) sent us 1,210 suspected 
MRSA primary isolates consecutively collected from hu-
man patients. For quality control, all isolates were cultured 
and investigated for mecA/femA by PCR at the Austrian 
National Reference Centre (3). Of the 1,210 isolates, 1,098 
(90.7%) were conﬁ  rmed to be MRSA; the other 112 (9.3%) 
were either methicillin-sensitive S. aureus or were not S. 
aureus and therefore were excluded from the MRSA reg-
istry.
Most molecular biological investigations (DNA isola-
tion, detection of the Panton-Valentine leukocidin [PVL] 
genes lukS-lukF, PFGE, spa typing) were performed as de-
scribed (3). Determination of staphylococcal cassette chro-
mosome mec (SCCmec) subtypes was performed by PCR 
according to Boye et al. (4). Multilocus sequence typing 
(MLST) PCR was performed according to Enright et al. 
(5). Sequence reactions were conducted by using BigDye 
ﬂ  uorescent terminators (Applied Biosystems, Foster City, 
CA, USA). Sequencing was performed on the ABI PRISM 
310 Genetic Analyzer (Applied Biosystems). Sequence 
types were assigned according to the S. aureus MLST data-
base with use of the typing software at www.mlst.net (6).
Etest showed resistance patterns of the MRSA ST398 
isolates to the following antimicrobial agents: ciproﬂ  oxa-
cin, clindamycin, erythromycin, fosfomycin, fusidic acid, 
gentamicin, moxiﬂ  oxacin, mupirocin, rifampin, and vanco-
mycin. Resistance to doxycycline was determined by using 
the disk diffusion test. Data were interpreted according to 
the guidelines of the Clinical and Laboratory Standards In-
stitute antimicrobial susceptibility testing standards, where 
available.
Demographic information and data from patient his-
tories were systematically collected by using standardized 
questionnaires and were interpreted by physicians and in-
fection control teams in hospitals as well as by physicians 
working in outpatient care. Infection and colonization were 
differentiated according to deﬁ  nitions from the Centers for 
Disease Control and Prevention (7) and interpreted by a 
physician.
Of the 1,098 primary MRSA isolates, 21 could not be 
digested by the restriction enzyme SmaI and were there-
fore investigated further (Table). All 21 patients (14 male, 
7 female; median age 58 years, range 1–83 years) harbored 
MRSA of clonal lineage ST398. Although MRSA ST398 
is suspected of being able to acquire virulence factor genes 
(1), only 5 patients were infected, whereas 15 were colo-
nized. Status was unknown for 1. Of the 15 colonization 
cases, 12 were detected by screening. Regarding the infec-
tions, 4 cases were of minor clinical relevance, but 1 case 
(isolate no. 3332) showed progression of major clinical rel-
evance: a 64-year-old pig farmer had received a prosthetic 
knee, and postoperative joint empyema with MRSA ST398 
developed soon afterwards.
The ﬁ  rst MRSA isolates in which ST398 was detected 
were collected in France during 1996–2002 (8). However, 
most publications concerning MRSA ST398 refer to sam-
ples collected since 2004 (9–11). In our institute, the ﬁ  rst 
isolate belonging to ST398 was detected in January 2006, 
although we have investigated 2,657 MRSA isolates from 
persons all over Austria since 1996. Therefore, we assume 
that the emergence of MRSA ST398 in Austria is rather 
recent. Until now, this MRSA strain seemed to be restricted 
to Upper Austria, although pig farming is equally common 
in Lower Austria and in Styria. It might be interesting to 
investigate the reason for the varying prevalence of MRSA 
ST398 in different regions of Austria.
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Our results correspond well with published data. 
SCCmec type V was predominant in our isolates, as has been 
found in Germany (9). One isolate harbored SCCmec type 
IV, but no type III, as has been reported in the Netherlands 
(12). None of our isolates harbored PVL genes, which con-
ﬁ  rms that the lukF/lukS genes are not necessarily present in 
community-acquired MRSA. Apparently, some community-
acquired MRSA types (e.g., ST30, ST80, ST152) are PVL 
positive in most cases, whereas others (e.g., ST398) are not. 
However, although all the MRSA ST398 isolates found in 
Europe to date were PVL negative, a PVL-positive MRSA 
ST398 strain was recently detected in China (13).
The spa types among our isolates were t011, t034 (both 
commonly found in ST398), and t2346. They are closely 
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Table. Clinical MRSA isolates of clonal lineage ST398, Upper Austria, January 2006–May 2008* 
Isolate
spa
type
SCCmec 
group Resistance
Patient
age, y/ 
sex
Sample
source Diagnosis
Infected or 
colonized Hospitalized
Profession,
direct animal 
contact
2753 t2346 V CLI, DOX, 
ERY
1/M Throat Pyodermatitis I (SST) Yes Grandson of pig 
farmer (son of 
2754), yes
2064 t011 V CLI, DOX, 
ERY
54/M Wound
smear
Gouty tophus I (SST) Yes Pig farmer, yes
3190 t011 V CLI, DOX, 
ERY
48/M Wound
smear
Decubitus ulcers I (SST) Yes Construction
worker, no
3332 t011 V DOX 64/M Wound
smear, joint 
puncture fluid
Joint empyema I (BJ) Yes Pig farmer, yes
3509 t011 V DOX 80/M BAL COPD I
(pneumonia)
Yes Caster,
unknown
1960 t011 V DOX 62/M Screening
conjunctival
swab
Paroxysmal 
tachycardia
C Yes (ICU) Farmer, yes
2023 t011 V CLI, DOX, 
ERY
68/M Screening
wound smear
Peripheral
arterial occlusive 
disease
C Yes Pig farmer, yes
2167 t011 V DOX 47/M Screening
tracheal
secretion
Epidural
hematoma
C Yes (ICU) Agricultural
worker, yes
2256 t011 V DOX 73/M Screening
wound smear
Ulcus cruris C Yes Cattle and pig 
farmer, yes
2726 t034 IV – 50/M Screening
nose swab
Pneumothorax C Yes Unknown
2754 t2346 V CLI, DOX, 
ERY
33/F Screening
nose, throat
swab
Premature
delivery
C No Daughter of pig 
farmer, yes
2770 t011 V CLI, DOX, 
ERY
81/F Screening
wound smear
Ulcus cruris C No Farmer, yes
2832 t011 V CLI, DOX, 
ERY
79/F Screening
wound smear
Ulcus cruris C No Pig farmer, yes
2909 t011 V DOX 79/M Screening
wound smear
Ulcus cruris C No Pig farmer, yes
3078 t011 V CLI, DOX, 
ERY
42/M Screening
nose swab
Erysipelas, 
septicemia
C Yes Farmer, yes
3195 t011 V – 69/M Wound
smear
Intertrigo C Yes Retired farmer 
(hens), yes
3335 t011 V DOX 65/F Screening
axilla, nose, 
groin
Screening C No Wife of pig 
farmer 3332, 
yes
3336 t011 V DOX 32/M Nose, wound 
smear
Screening C No Son of pig 
farmers 3332 
and 3335, yes
3391 t011 V CLI, DOX, 
ERY
83/F Feces Polytrauma C Yes Retired, no
3456 t011 V DOX 69/F BAL Hemoptysis, 
bronchitis
C Yes Cleaner, no
3008 t011 V DOX 48/F Unknown Unknown Unknown Unknown Farmer, yes
*MRSA, methicillin-resistant Staphylococcus aureus; SCC, staphylococcal cassette chromosome; CLI, clindamycin; DOX, doxycycline; ERY, 
erythromycin; I, infected; SST, skin and soft tissue infection; C, colonized; BJ, bone and joint infection; BAL, bronchioalveolar lavage; COPD, chronic 
obstructive pulmonary disease; ICU, intensive care unit; –, no resistance found. related to each other as well as to other types belonging to 
ST398.
Antimicrobial drug–susceptibility testing showed that 
19 of 21 isolates were resistant to doxycyline, 9 of which 
were also resistant to clindamycin and erythromycin. All 
isolates were susceptible to the other drugs tested. Only 2 
isolates were fully susceptible to all agents tested. These 
antimicrobial drug–resistance proﬁ  les might reﬂ  ect the fre-
quent use of tetracyclines in veterinary medicine; in Aus-
tria, two thirds of all antimicrobial drugs used in veterinary 
practice, especially in pig and poultry farming, are tetra-
cycline derivatives (14), a situation similar to that in other 
European countries (11,12). Therefore, it is not surprising 
that our resistance proﬁ  les correspond well with those from 
the Netherlands, Germany, and France (9,12,15).
The only isolate harboring spa type t034 was also the 
only isolate harboring SCCmec IV and is 1 of the 2 iso-
lates that were fully susceptible to all antimicrobial drugs 
tested. Among all MRSA isolates, the percentage of ST398 
in Upper Austria was 1.3% (6/463) in 2006, 2.3% (9/392) 
in 2007, and 2.5% (6/243) in 2008 (January–May). These 
percentages agree with data from Witte et al., who reported 
that MRSA ST398 is not frequent among S. aureus in Ger-
many or the United Kingdom (9). However, the proportion 
of MRSA isolates that are ST398 has slightly increased in 
Upper Austria.
Most patients discussed in this article had had contact 
with animals. MRSA ST398 is known to be associated with 
animal contact, especially with pigs and cows (8–10,12). In 
the Netherlands and in France, the MRSA carriage rate is 
substantially higher for pig farmers and veterinarians than 
for the general population (11,15). In our study, 10 patients 
were pig farmers or direct relatives of pig farmers, and 6 
were farmers (raised hens or unknown animal species). 
The animal contact status of 2 was unknown. In 2008, 3 of 
our patients had no direct animal contact; possible MRSA 
transmission from healthcare workers or other sources was 
not investigated. Thus, the question arises as to whether 
these isolates might represent more spread of this sequence 
type strain outside pig farms.
Conclusions
MRSA of clonal lineage ST398 has emerged in hu-
mans in Austria. Moreover, it is not conﬁ  ned to Europe but 
has also been detected in China (13), Thailand, and Canada 
(11). This ﬁ  nding indicates a great potential for spread, 
quantitatively as well as geographically. Because the in-
ternational meat and livestock market is active, the stage 
is set for rapid spread.  In addition, the largest exporter of 
live pigs in Europe is the Netherlands, and up to 39% of 
pigs from the Netherlands carry MRSA in their nares (12). 
Thus, we suggest intensiﬁ  ed establishment of collabora-
tions between laboratories from different countries.
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